Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
11th July, 2023
A webcast replay will be available approximately 48-hrs after the live webcast.
Johnson & Johnson (NYSE: JNJ) will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin, Company Group Chairman Cardiovascular & Specialty Solutions Group (CSS), Anthony (Tony) Long, VP, Clinical Research, Medical Affairs, Preclinical Research and Jasmina Brooks, President Biosense Webster will represent the Company in a session scheduled at 2:00 pm (Eastern Time).
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
Medtech Special
- Roche revolutionizes diagnostics with cobas mass spec solution
- Abbott announces first-in-world leadless pacing procedures in the left bundle branch area of the heart
- BD and Babson Diagnostics launch innovative fingertip blood testing to health care organizations
- Implantica adds a ninth RefluxStop™ Center of Excellence
- Medtech firm Getinge opens new Experience Centre in Mumbai
- WHO announces first prequalification of tuberculosis diagnostic test
- Chi Mei Medical Center and Microsoft: Transforming Healthcare with AI and Smart Technology
Artificial Intelligence Breakthroughs
- Samsung invests in generate biomedicines to advance AI-driven therapeutics
- India-based 'Mahajan Imaging and Labs' launches AI-powered lab in Gurugram
- Saudi Arabia to develop AI and data science solution for tackling tuberculosis
- How AI is Propelling Radiology & Medical Imaging Capabilities
- Generative AI: Revolutionizing Diagnostics and Personalized Care
- Indian startup Qure.ai joins hands with Roche to transform healthcare capabilities in APAC
- A10 Networks Launches Integrated AI and Security Solutions to Strengthen Cybersecurity in Healthcare and Beyond
Robots In Medtech
- India's SS Innovations makes history with first robotic cardiac surgery in Indonesia
- Momentis Surgical Secures FDA Clearance for Advanced Anovo® Robotic Platform, Setting New Standards in Single-Incision Surgery
- Momentis Surgical expands to general surgery market with FDA 510(k) clearance for its Anovo Robotic system
- Intuitive and India-based KIMS Hospitals sign MoU to launch 25 new robotic surgery programmes
- ZEISS introduces its latest Robotic Visualisation System for neuro surgery
- Surgical robotics pioneer Intuitive opens Global Capability Centre in Bengaluru, India
- First-of-its-kind robotic cardiac CoE unveiled in Bengaluru, India
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer